🇺🇸 FDA
Patent

US 6756036

Methods for treating cancer using PSCA antibodies and fragments thereof

expired A61KA61K2039/505A61K31/704

Quick answer

US patent 6756036 (Methods for treating cancer using PSCA antibodies and fragments thereof) held by The Regents of the University of California expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2039/505, A61K31/704, A61K38/00, A61K39/395